Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-cetuximab IgE testing before cetuximab treatment
2009-016968-37Phase 2Completed
- Sponsor
- Centre François Baclesse
- Start
- Nov 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in colon cancer and head and neck cancer (HNC), sponsored by Centre François Baclesse. Primary endpoint: Utility of anti-cetuximab IgE measurement. Started Nov 2009; status: completed.
02
Drugs
cetuximab
03
Conditions
colon cancerhead and neck cancer (HNC)
Beyond the preview
Go deeper on 2009-016968-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016968-37.